Listed

Milestone Pharmaceuticals Inc.

MISTNasdaqCIK 1408443HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$559.0k, Q2 FY2026
Operating income−$25.6m, Q2 FY2026
Net income−$28.6m, Q2 FY2026
Milestone Pharmaceuticals Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reported0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figurenot reportednot reported0.2Revenue, Q1 FY2026, three months to 2026-03-31$238.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure0.6Revenue, Q2 FY2026, three months to 2026-06-30$559.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reported0.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure0.0Cost of revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figurenot reportednot reported0.0Cost of revenue, Q1 FY2026, three months to 2026-03-31$14.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure0.0Cost of revenue, Q2 FY2026, three months to 2026-06-30$32.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure
Research and development$m6.7Research and development, Q3 FY2023, three months to 2023-09-30$6.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001558370-24-015147.Report this figure5.5Research and development, Q4 FY2023, three months to 2023-12-31$5.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-13, accession 0001558370-25-002849. Derived: 12-month figure less the 9-month figure.Report this figure3.6Research and development, Q1 FY2024, three months to 2024-03-31$3.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001558370-25-007648.Report this figure2.8Research and development, Q2 FY2024, three months to 2024-06-30$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001558370-25-011141.Report this figure4.0Research and development, Q3 FY2024, three months to 2024-09-30$4.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figure3.9Research and development, Q4 FY2024, three months to 2024-12-31$3.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-20, accession 0001104659-26-032415. Derived: 12-month figure less the 9-month figure.Report this figure5.0Research and development, Q1 FY2025, three months to 2025-03-31$5.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure3.7Research and development, Q2 FY2025, three months to 2025-06-30$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure3.9Research and development, Q3 FY2025, three months to 2025-09-30$3.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figure5.5Research and development, Q4 FY2025, three months to 2025-12-31$5.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-20, accession 0001104659-26-032415. Derived: 12-month figure less the 9-month figure.Report this figure3.3Research and development, Q1 FY2026, three months to 2026-03-31$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure3.5Research and development, Q2 FY2026, three months to 2026-06-30$3.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure
Selling, general and administrative$mnot reportednot reportednot reportednot reportednot reportednot reportednot reported8.9Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$8.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figurenot reportednot reportednot reported22.6Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$22.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure
Operating income$m(15.4)Operating income, Q3 FY2023, three months to 2023-09-30−$15.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001558370-24-015147.Report this figure(13.8)Operating income, Q4 FY2023, three months to 2023-12-31−$13.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-13, accession 0001558370-25-002849. Derived: 12-month figure less the 9-month figure.Report this figure(10.5)Operating income, Q1 FY2024, three months to 2024-03-31−$10.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001558370-25-007648.Report this figure(9.7)Operating income, Q2 FY2024, three months to 2024-06-30−$9.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001558370-25-011141.Report this figure(9.6)Operating income, Q3 FY2024, three months to 2024-09-30−$9.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figure(12.3)Operating income, Q4 FY2024, three months to 2024-12-31−$12.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-20, accession 0001104659-26-032415. Derived: 12-month figure less the 9-month figure.Report this figure(20.5)Operating income, Q1 FY2025, three months to 2025-03-31−$20.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure(12.5)Operating income, Q2 FY2025, three months to 2025-06-30−$12.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure(11.8)Operating income, Q3 FY2025, three months to 2025-09-30−$11.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figure(17.3)Operating income, Q4 FY2025, three months to 2025-12-31−$17.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-20, accession 0001104659-26-032415. Derived: 12-month figure less the 9-month figure.Report this figure(23.7)Operating income, Q1 FY2026, three months to 2026-03-31−$23.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure(25.6)Operating income, Q2 FY2026, three months to 2026-06-30−$25.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure
Interest expense$m0.8Interest expense, Q3 FY2023, three months to 2023-09-30$841.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-13, accession 0001558370-23-018665.Report this figure0.9Interest expense, Q4 FY2023, three months to 2023-12-31$857.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-21, accession 0001558370-24-003666. Derived: 12-month figure less the 9-month figure.Report this figure0.9Interest expense, Q1 FY2024, three months to 2024-03-31$872.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-13, accession 0001558370-24-007860.Report this figure0.9Interest expense, Q2 FY2024, three months to 2024-06-30$887.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-12, accession 0001558370-25-011141.Report this figure0.9Interest expense, Q3 FY2024, three months to 2024-09-30$903.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figure0.9Interest expense, Q4 FY2024, three months to 2024-12-31$919.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-20, accession 0001104659-26-032415. Derived: 12-month figure less the 9-month figure.Report this figure0.9Interest expense, Q1 FY2025, three months to 2025-03-31$935.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure1.0Interest expense, Q2 FY2025, three months to 2025-06-30$951.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure1.0Interest expense, Q3 FY2025, three months to 2025-09-30$967.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figure1.0Interest expense, Q4 FY2025, three months to 2025-12-31$985.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-20, accession 0001104659-26-032415. Derived: 12-month figure less the 9-month figure.Report this figure4.1Interest expense, Q1 FY2026, three months to 2026-03-31$4.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure4.7Interest expense, Q2 FY2026, three months to 2026-06-30$4.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(15.1)Net income, Q3 FY2023, three months to 2023-09-30−$15.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001558370-24-015147.Report this figure(13.6)Net income, Q4 FY2023, three months to 2023-12-31−$13.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-13, accession 0001558370-25-002849. Derived: 12-month figure less the 9-month figure.Report this figure(10.4)Net income, Q1 FY2024, three months to 2024-03-31−$10.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-14, accession 0001558370-25-007648.Report this figure(9.4)Net income, Q2 FY2024, three months to 2024-06-30−$9.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-12, accession 0001558370-25-011141.Report this figure(9.4)Net income, Q3 FY2024, three months to 2024-09-30−$9.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figure(12.4)Net income, Q4 FY2024, three months to 2024-12-31−$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-20, accession 0001104659-26-032415. Derived: 12-month figure less the 9-month figure.Report this figure(20.8)Net income, Q1 FY2025, three months to 2025-03-31−$20.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure(13.0)Net income, Q2 FY2025, three months to 2025-06-30−$13.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure(11.9)Net income, Q3 FY2025, three months to 2025-09-30−$11.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figure(17.4)Net income, Q4 FY2025, three months to 2025-12-31−$17.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-20, accession 0001104659-26-032415. Derived: 12-month figure less the 9-month figure.Report this figure(26.1)Net income, Q1 FY2026, three months to 2026-03-31−$26.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure(28.6)Net income, Q2 FY2026, three months to 2026-06-30−$28.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure
Diluted EPS$ per share(0.35)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001558370-24-015147.Report this figurenot reported(0.21)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001558370-25-007648.Report this figure(0.14)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001558370-25-011141.Report this figure(0.14)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figurenot reported(0.31)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure(0.20)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure(0.12)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figurenot reported(0.20)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure(0.21)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure
Basic EPS$ per share(0.35)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001558370-24-015147.Report this figurenot reported(0.21)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001558370-25-007648.Report this figure(0.14)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001558370-25-011141.Report this figure(0.14)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figurenot reported(0.31)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure(0.20)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure(0.12)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figurenot reported(0.20)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure(0.21)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure

Balance sheet

Cash and equivalents$169.7m, Q2 FY2026
Long-term debt$59.2m, Q2 FY2026
Shareholders' equity$18.2m, Q2 FY2026
Milestone Pharmaceuticals Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m9.9Cash and equivalents, Q3 FY2023, at 2023-09-30$9.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001558370-23-018665.Report this figure13.8Cash and equivalents, FY2023, at 2023-12-31$13.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-13, accession 0001558370-25-002849.Report this figure10.1Cash and equivalents, Q1 FY2024, at 2024-03-31$10.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-13, accession 0001558370-24-007860.Report this figure13.3Cash and equivalents, Q2 FY2024, at 2024-06-30$13.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001558370-24-011603.Report this figure12.8Cash and equivalents, Q3 FY2024, at 2024-09-30$12.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001558370-24-015147.Report this figure25.3Cash and equivalents, FY2024, at 2024-12-31$25.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-20, accession 0001104659-26-032415.Report this figure45.1Cash and equivalents, Q1 FY2025, at 2025-03-31$45.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001558370-25-007648.Report this figure42.5Cash and equivalents, Q2 FY2025, at 2025-06-30$42.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001558370-25-011141.Report this figure46.7Cash and equivalents, Q3 FY2025, at 2025-09-30$46.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figure73.0Cash and equivalents, FY2025, at 2025-12-31$73.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure71.3Cash and equivalents, Q1 FY2026, at 2026-03-31$71.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure170Cash and equivalents, Q2 FY2026, at 2026-06-30$169.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure
Current assets$m84.8Current assets, Q3 FY2023, at 2023-09-30$84.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001558370-23-018665.Report this figure73.0Current assets, FY2023, at 2023-12-31$73.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-13, accession 0001558370-25-002849.Report this figure94.0Current assets, Q1 FY2024, at 2024-03-31$94.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0001558370-24-007860.Report this figure87.4Current assets, Q2 FY2024, at 2024-06-30$87.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001558370-24-011603.Report this figure81.0Current assets, Q3 FY2024, at 2024-09-30$81.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001558370-24-015147.Report this figure73.9Current assets, FY2024, at 2024-12-31$73.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-20, accession 0001104659-26-032415.Report this figure60.5Current assets, Q1 FY2025, at 2025-03-31$60.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001558370-25-007648.Report this figure46.2Current assets, Q2 FY2025, at 2025-06-30$46.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001558370-25-011141.Report this figure86.7Current assets, Q3 FY2025, at 2025-09-30$86.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figure112Current assets, FY2025, at 2025-12-31$111.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure192Current assets, Q1 FY2026, at 2026-03-31$192.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure180Current assets, Q2 FY2026, at 2026-06-30$180.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure
Total assets$m87.1Total assets, Q3 FY2023, at 2023-09-30$87.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001558370-23-018665.Report this figure75.2Total assets, FY2023, at 2023-12-31$75.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-13, accession 0001558370-25-002849.Report this figure96.0Total assets, Q1 FY2024, at 2024-03-31$96.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0001558370-24-007860.Report this figure89.2Total assets, Q2 FY2024, at 2024-06-30$89.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001558370-24-011603.Report this figure82.7Total assets, Q3 FY2024, at 2024-09-30$82.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001558370-24-015147.Report this figure75.5Total assets, FY2024, at 2024-12-31$75.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-20, accession 0001104659-26-032415.Report this figure61.9Total assets, Q1 FY2025, at 2025-03-31$61.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001558370-25-007648.Report this figure47.4Total assets, Q2 FY2025, at 2025-06-30$47.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001558370-25-011141.Report this figure87.8Total assets, Q3 FY2025, at 2025-09-30$87.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figure114Total assets, FY2025, at 2025-12-31$113.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure194Total assets, Q1 FY2026, at 2026-03-31$193.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure182Total assets, Q2 FY2026, at 2026-06-30$181.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure
Current liabilities$m8.1Current liabilities, Q3 FY2023, at 2023-09-30$8.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001558370-23-018665.Report this figure7.2Current liabilities, FY2023, at 2023-12-31$7.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-13, accession 0001558370-25-002849.Report this figure4.1Current liabilities, Q1 FY2024, at 2024-03-31$4.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0001558370-24-007860.Report this figure4.6Current liabilities, Q2 FY2024, at 2024-06-30$4.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001558370-24-011603.Report this figure5.3Current liabilities, Q3 FY2024, at 2024-09-30$5.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001558370-24-015147.Report this figure8.1Current liabilities, FY2024, at 2024-12-31$8.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-20, accession 0001104659-26-032415.Report this figure13.0Current liabilities, Q1 FY2025, at 2025-03-31$13.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001558370-25-007648.Report this figure9.3Current liabilities, Q2 FY2025, at 2025-06-30$9.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001558370-25-011141.Report this figure10.5Current liabilities, Q3 FY2025, at 2025-09-30$10.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figure14.0Current liabilities, FY2025, at 2025-12-31$14.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure20.9Current liabilities, Q1 FY2026, at 2026-03-31$20.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure22.2Current liabilities, Q2 FY2026, at 2026-06-30$22.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure
Total liabilities$m58.6Total liabilities, Q3 FY2023, at 2023-09-30$58.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001558370-23-018665.Report this figure58.5Total liabilities, FY2023, at 2023-12-31$58.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-13, accession 0001558370-25-002849.Report this figure56.1Total liabilities, Q1 FY2024, at 2024-03-31$56.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0001558370-24-007860.Report this figure57.3Total liabilities, Q2 FY2024, at 2024-06-30$57.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001558370-24-011603.Report this figure58.7Total liabilities, Q3 FY2024, at 2024-09-30$58.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001558370-24-015147.Report this figure62.4Total liabilities, FY2024, at 2024-12-31$62.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-20, accession 0001104659-26-032415.Report this figure68.0Total liabilities, Q1 FY2025, at 2025-03-31$68.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001558370-25-007648.Report this figure65.2Total liabilities, Q2 FY2025, at 2025-06-30$65.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001558370-25-011141.Report this figure67.2Total liabilities, Q3 FY2025, at 2025-09-30$67.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figure71.8Total liabilities, FY2025, at 2025-12-31$71.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure158Total liabilities, Q1 FY2026, at 2026-03-31$157.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure163Total liabilities, Q2 FY2026, at 2026-06-30$163.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure
Long-term debt$m48.9Long-term debt, Q3 FY2023, at 2023-09-30$48.9m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-13, accession 0001558370-23-018665.Report this figure49.8Long-term debt, FY2023, at 2023-12-31$49.8m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-03-13, accession 0001558370-25-002849.Report this figure50.6Long-term debt, Q1 FY2024, at 2024-03-31$50.6m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-13, accession 0001558370-24-007860.Report this figure51.5Long-term debt, Q2 FY2024, at 2024-06-30$51.5m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-08, accession 0001558370-24-011603.Report this figure52.4Long-term debt, Q3 FY2024, at 2024-09-30$52.4m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-12, accession 0001558370-24-015147.Report this figure53.4Long-term debt, FY2024, at 2024-12-31$53.4m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-03-20, accession 0001104659-26-032415.Report this figure54.3Long-term debt, Q1 FY2025, at 2025-03-31$54.3m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-14, accession 0001558370-25-007648.Report this figure55.2Long-term debt, Q2 FY2025, at 2025-06-30$55.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-08-12, accession 0001558370-25-011141.Report this figure56.2Long-term debt, Q3 FY2025, at 2025-09-30$56.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figure57.2Long-term debt, FY2025, at 2025-12-31$57.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure58.2Long-term debt, Q1 FY2026, at 2026-03-31$58.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure59.2Long-term debt, Q2 FY2026, at 2026-06-30$59.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure
Shareholders' equity$m28.5Shareholders' equity, Q3 FY2023, at 2023-09-30$28.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001558370-24-015147.Report this figure16.8Shareholders' equity, FY2023, at 2023-12-31$16.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-20, accession 0001104659-26-032415.Report this figure39.9Shareholders' equity, Q1 FY2024, at 2024-03-31$39.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-12, accession 0001558370-25-011141.Report this figure32.0Shareholders' equity, Q2 FY2024, at 2024-06-30$32.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figure24.0Shareholders' equity, Q3 FY2024, at 2024-09-30$24.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figure13.1Shareholders' equity, FY2024, at 2024-12-31$13.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure(6.1)Shareholders' equity, Q1 FY2025, at 2025-03-31−$6.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure(17.7)Shareholders' equity, Q2 FY2025, at 2025-06-30−$17.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure20.5Shareholders' equity, Q3 FY2025, at 2025-09-30$20.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001104659-25-109689.Report this figure41.8Shareholders' equity, FY2025, at 2025-12-31$41.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure36.0Shareholders' equity, Q1 FY2026, at 2026-03-31$36.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure18.2Shareholders' equity, Q2 FY2026, at 2026-06-30$18.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001104659-26-094435.Report this figure

Cash flow

Operating cash flow−$22.7m, Q2 FY2026
Capital expenditure$26.0k, Q2 FY2026
Milestone Pharmaceuticals Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(12.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$12.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001558370-24-015147. Derived: 9-month figure less the 6-month figure.Report this figure(9.8)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$9.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-13, accession 0001558370-25-002849. Derived: 12-month figure less the 9-month figure.Report this figure(8.9)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$8.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001558370-25-007648.Report this figure(6.1)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$6.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001558370-25-011141. Derived: 6-month figure less the 3-month figure.Report this figure(7.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$7.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001104659-25-109689. Derived: 9-month figure less the 6-month figure.Report this figure(6.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$6.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-20, accession 0001104659-26-032415. Derived: 12-month figure less the 9-month figure.Report this figure(14.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$14.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure(12.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$12.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001104659-26-094435. Derived: 6-month figure less the 3-month figure.Report this figure(9.7)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$9.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001104659-25-109689. Derived: 9-month figure less the 6-month figure.Report this figure(12.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$12.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-20, accession 0001104659-26-032415. Derived: 12-month figure less the 9-month figure.Report this figure(16.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$16.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure(22.7)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$22.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001104659-26-094435. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$18.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001558370-24-015147. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$31.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-13, accession 0001558370-25-002849. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$4.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001104659-25-109689. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$22.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-20, accession 0001104659-26-032415. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$11.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001104659-26-094435. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001104659-25-109689. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2025, three months to 2025-12-31$283.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-20, accession 0001104659-26-032415. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$45.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001104659-26-059752.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$26.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001104659-26-094435. Derived: 6-month figure less the 3-month figure.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.